Top Markets
#1 DogBull DogBull +108.53%
#2 MarsCoin MarsCoin +84.53%
#3 Siacoin Siacoin +54.45%
#4 ADO Protocol ADO Protocol +52.61%
#5 The Bitcoin Bull The Bitcoin Bull +28.19%
#6 Ontology Gas Ontology Gas +26.26%
#7 Apertum Apertum +16.17%
#8 Arowana Arowana +12.72%
#9 Pons Pons +12.09%
#10 Useless Coin Useless Coin +11.98%
Coin of the day
DogBull DogBull
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Kwality Pharmaceuticals Limited Kwality Pharmaceuticals Limited

Kwality Pharmaceuticals Limited

KPL
Classificação em ações #14839
Kwality Pharmaceuticals Ltd. is dedicated to developing and manufacturing a... Kwality Pharmaceuticals Ltd. is dedicated to developing and manufacturing a diverse range of pharmaceutical products, presented in various dosage forms. Their extensive portfolio includes items such as tablets, boluses, oral liquid medications, sterile injectable powders, topical ointments, ophthalmic solutions, capsules, liquid injectables, dry powders intended for oral suspensions, and external preparations. The enterprise was established by Ramesh Arora on May 4, 1983, and its principal operations are based in Amritsar, India.
Preço da ação
$37.48
Valor de mercado
$388.86M
Variação (1 dia)
3.35%
Variação (1 ano)
232.76%
País
IN
Negociar Kwality Pharmaceuticals Limited (KPL)

Categoria

Healthcare
Receita da Kwality Pharmaceuticals Limited (KPL)
Receita em Sep 2026 TTM: 0
De acordo com os últimos relatórios financeiros da Kwality Pharmaceuticals Limited, a receita atual da empresa (TTM) é 0. Em 2026, a empresa obteve uma receita de 0 igual a a receita do ano 2026, que foi de 0. A receita é o valor total gerado pela venda de bens ou serviços. Ao contrário do lucro, nenhuma despesa é subtraída.
Histórico de receita da Kwality Pharmaceuticals Limited de 2026 a 2026
Receita no final de cada ano
Ano Receita Alterar
Não há dados suficientes para as datas fornecidas.
Receita de empresas similares ou concorrentes
Empresa Receita Diferença de Receita País
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 $2.54B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 - -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 - -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
 - -
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
 $830.81M -
US